United States: Animal Supplements Still In Limbo, Facing Increased FDA Scrutiny

The thousands of food, agriculture and life sciences companies regulated by the federal government already face a barrage of complicated regulations. Add in significant regulatory uncertainty and a major reorganization of the governing agency and you see the current predicament of the animal supplement industry.

In this post, we'll break down the current structure of the agencies governing the animal dietary supplement industry, detail the regulatory conflict between human and animal supplements, and offer some tips for animal supplement companies that will likely face increased FDA scrutiny and enforcement in the near future.

A major reshuffling

On January 13, 2013, the Federal Register published a Final Notice amending the Statement of Organization Functions and Delegations of Authority for the Department of Health and Human Services (HHS) on the reorganization within the FDA. This reorganization, approved prior to the publication in the Federal Register, brought the Center for Veterinary Medicine (CVM) under the Center for Food Safety and Applied Nutrition (CFSAN), thereby creating the new "Office of Foods and Veterinary Medicine" (OFVM). This reorganization happened in large part because of the mandates under the Food Safety and Modernization Act (FSMA) affecting both human and animal food chains. The goal in bringing these centers under one office was to hopefully create a more coordinated approach to the FDA's risk-based mandates related to the safety of the U.S. food chain.

On its face, this reorganization may make sense, provided that all of the issues the former CVM dealt with were related only to animals that are part of the human food chain (i.e., livestock). This is not the case, however, as the CVM was also charged with reviewing and approving animal drugs, dietary supplements, feed, and feed additives for animals defined as companion animals, such as dogs, cats and horses. This consolidation has caused the animal industry to wonder what impact the reorganization will have on its business, particularly for companies producing animal supplements. This lack of clarity for animal supplement manufacturers initially arose from an FDA statement related to the applicability of the Dietary Supplement Health and Education Act (DSHEA) and the nature of animal supplements themselves. Combined with the January 2013 reorganization of the Centers for Veterinary Medicines, the issue remains a major source of confusion and risk for industry members.

Human vs. animal supplements

Before DSHEA, human dietary supplements were inconsistently regulated as a food, a drug, or not regulated at all. These products were subject to inconsistent and seemingly random enforcement with varying requirements levied upon manufacturers based upon a case-by-case consideration of the product in question. Further, the animal supplement market was essentially unregulated. Companies were left with a market rife with confusion and varying product qualities and types. As a result, DSHEA was enacted to define dietary supplements as their own category of FDA-regulated products. These products would be regulated similarly to food. Thus, DSHEA added to the FDCA a definition for "dietary supplements" that states in relevant part:

  • The term "dietary supplement"—

    (1) means a product (other than tobacco) intended to supplement the diet that bears or contains one or more of the following dietary ingredients...[redacted]

    Except for purposes of section 201(g), a dietary supplement shall be deemed to be a food within the meaning of this Act.

21 U.S.C. § 321(ff). (emphasis added). Simply, DSHEA defines dietary supplements as products which are treated like food products by the FDA. 

However, in 1996 and reiterated again in 2002, the FDA stated that DSHEA only applied to human dietary supplements and not animal supplements. The FDA went on to state that it was the position of the agency that animal supplements could and would be regulated as either a drug, food or feed additive. Specifically, the FDA stated that,

  • ...substances marketed as dietary supplements for humans still fall under the pre-DSHEA regulatory scheme when marketed for animals; that is, they are considered food, food additives, new animal drugs, or [Generally Recommended As Safe] depending on the intended use. Most of these types of products on the market would be considered unapproved and unsafe food additives or new drugs. The rationale behind this conclusion was the lack of language both surrounding DSHEA as well as the lack of language in DSHEA concerning animal supplements. Based on the lack of language, the FDA concluded that the Act was primarily concerned with improving the health of humans in the U.S. The FDA further stated that it was the agency's position that animal supplements could be regulated as an animal drug, a feed or a feed additive.

(61 FR § 17706.) Having made the pronouncement that DSHEA only applies to human supplements, the FDA has left a large market segment unregulated when the product does not fit within the applicable definitions of regulated products, specifically feed, feed additives or animal drugs:

  • Animal feed is defined as an article of food or animal consumption. 
  • A drug is defined as an article intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease.
  • A feed additive is typically any substance which is expected to become a component of animal food either as an ingredient or by top dressing a feed or placement in the animal's water.

A look at the animal supplement market reveals products similar to those products found in the human dietary supplement markets – products intended to affect or support a structure or function of the body. These products do not meet the definitions of a feed, feed additive or drug. Without the application of DSHEA, the result has been, to date, a virtually unregulated market. 

As a result, the FDA will regulate animal dietary supplements going forward in light of this consolidation and the ever increasing enforcement actions of the FDA with its authority under the Food Safety and Modernization Act (FSMA), enacted in 2011.

The FDA's enforcement stance

Many animal supplements do not in and of themselves provide nutrition. They are also not intended for use in the diagnosis, cure, or mitigation of disease, and they are not intended to become part of animal feed. Therefore, there remains a huge portion of the animal supplement product market that is relatively unregulated. To further complicate the issue for the animal health industry, the FDA has historically found animal dietary supplements to be "technically in violation of the law, [but] they are of low enforcement priority except for when public or animal health concerns arise." However, certain events may change that enforcement stance. One impetus for change is the Food Safety Modernization Act. It represents the first time in 70 years that the U.S. has directly addressed food safety and the security of the U.S. food supply. As a result of the FSMA, the FDA is now moving quickly to implement the FMSA requirements and increase its enforcement efforts over both human and animal products. Manufacturers can therefore expect increased scrutiny over their products.

Little guidance exists from the FDA for companies in the animal supplement industry, and compliance requirements remain difficult to pin down. Industry members must carefully analyze the market strategy for those products that have crossed over from the human dietary supplement market to the animal health market, a trend that is occurring with more and more frequency. These products may be the first to be subject to increased FDA scrutiny as they are already the subject of regulatory filings and therefore on the FDA's "radar." Regardless, a thorough analysis of an animal supplement is prudent prior to market entry. Carefully study the marketing and advertising claims surrounding those products, including product labeling and product testing in order to reduce the chances that the FDA takes notice of the product and decides to act.

What does this mean for animal dietary supplement products? Like so many other areas, it is highly likely that the FDA will find a jurisdictional basis, most likely within the FSMA or related food regulations to promulgate new rules to cover the void created by the current regulations and previous FDA statements. Further, companies will still have to ensure that labeling comports with applicable regulations. For example, the agency has allowed certain health claims to appear on animal food, provided that such claims generally meet the requirements set forth in the Nutrition Labeling Education Act (NLEA).

It generally takes time for the enforcement actions of the FDA to catch up to the new regulations; typically the industry is given time to reconcile its actions to those new regulations. Here the unique challenge will be understanding how to reconcile the animal supplement industry's compliance efforts in light of the current lack of clear FDA guidance and regulatory requirements. Moving forward, and until the FSMA and the recent FDA reorganization have had ample time to mature, animal supplement companies would be well served to ensure that their packaging, labeling and claims comport with the NLEA. Additionally, these companies should take care in the marketing and advertising of these products to avoid enforcement actions by the agency, as it is most likely that these products will find themselves being regulated as an unapproved drug.

At Thompson Coburn we have a team of attorneys with years of experience dealing with FDA regulations, including, but not limited to, product analysis and approvals, product labeling, seizures, FSMA compliance, New Animal Drug Applications, cGMPs and detention proceedings. We would be happy to speak to you and your company on how we can assist you with your FDA regulated products.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions